• No results found

open-label

Xenon in the treatment of panic disorder: an open label study

Xenon in the treatment of panic disorder: an open label study

... This investigator-initiated study was performed under a prospective clinical trial protocol approved by the Institute of Mental Health and Addictology, which is accredited by the Ministry of Health of the Russian Fed- ...

10

An open label study of aripiprazole for methamphetamine induced psychosis

An open label study of aripiprazole for methamphetamine induced psychosis

... Methamphetamine (MA) is a psycho-stimulant drug with addictive and long lasting stimulant effects. Because of its wide availability and lower cost, methamphetamine has become one of the most commonly consumed illicit ...

9

Baclofen as relapse prevention in the treatment of Gamma  Hydroxybutyrate (GHB) dependence: an open label study

Baclofen as relapse prevention in the treatment of Gamma Hydroxybutyrate (GHB) dependence: an open label study

... Given these methodological limitations the current study should be considered explorative in nature. Given the currently rather limited information from both pre- clinical and clinical studies of GHB such an explorative ...

8

The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open  label study

The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open label study

... This was an open label study using flexible doses (100 mg/d – 1200 mg/d) of amisulpride. Patients with pre- dominantly negative symptoms, defined as a greater score on the negative than on the positive ...

8

The Effect of Curcumin on Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An Open Label Study

The Effect of Curcumin on Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An Open Label Study

... Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), recently re- named as systemic exertion intolerance disease (SEID), is a chronic and often disabling disease. Although the exact pathophysiological mechanism ...

11

EVALUATION OF ANTIUROLITHIC HERBAL FORMULA FOR UROLITHIASIS: A RANDOMIZED OPEN LABEL CLINICAL STUDY

EVALUATION OF ANTIUROLITHIC HERBAL FORMULA FOR UROLITHIASIS: A RANDOMIZED OPEN LABEL CLINICAL STUDY

... Materials and Method : The study was conducted with the design of purposive randomized open-label, end-blinded observation. The sample size and randomization were done by computer with generated statistical ...

6

Treatment of alcohol dependence with low dose topiramate: an open label controlled study

Treatment of alcohol dependence with low dose topiramate: an open label controlled study

... present open-label controlled study was to assess the efficacy and tolerability profile of low- dose topiramate as adjunctive treatment in alcohol depen- dence during the immediate post-detoxification ...

7

Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial

Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial

... There are several limitations to our pilot study that war- rant discussion. The purpose of this study was to assess the feasibility of studying ginkgo for the management of the vitiligo in a larger, blinded randomized ...

9

A prospective, open label, 24 week trial of methylcobalamin in the treatment of diabetic polyneuropathy

A prospective, open label, 24 week trial of methylcobalamin in the treatment of diabetic polyneuropathy

... prospective, open-label study on adult diabetic subjects with polyneuropathy who were given 1500 μgm/day of oral methylcobalamin over ...24-week open label study demonstrated that symptoms of ...

5

Rapid Visible Improvements in Onychomycosis: An Open Label Clinical Investigation of Kerasal NailTM

Rapid Visible Improvements in Onychomycosis: An Open Label Clinical Investigation of Kerasal NailTM

... cal treatment containing propylene glycol, urea and lactic acid. The ability of Kerasal Nail to improve the appearance of an affected nail was investigated in a 4-week open-label study. Patients aged ≥21 ...

10

Treatment of mucocutaneous manifestations in Behçet’s disease with anakinra: a pilot open label study

Treatment of mucocutaneous manifestations in Behçet’s disease with anakinra: a pilot open label study

... Two of six patients met the primary outcome of complete remission by month 6 (Table 1). Two patients met the criteria for partial response. Two patients were considered treatment failures. One patient terminated the ...

7

A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis

A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis

... randomized, open-label trial with 2 parallel arms of stand- ard antifungal therapy versus Tamoxifen augmented antifungal therapy during the first 2 weeks (induction phase) of treatment (see Figure ...

28

Acupuncture for patients with mild hypertension: study protocol of an open label multicenter randomized controlled trial

Acupuncture for patients with mild hypertension: study protocol of an open label multicenter randomized controlled trial

... One important limitation that may be present in this study is that it is an open-label trial. We design a waiting-list group as a blank controlled group. It is im- possible to execute a blinding method. In ...

10

Olmesartan for non alcoholic steatohepatitis complicated with hypertension: An open label study

Olmesartan for non alcoholic steatohepatitis complicated with hypertension: An open label study

... prospective open-label study was conducted in patients with biopsy-proven NASH, and who were recruited from the Kitasato University East Hospital, Sagamihara, Kana- gawa, ...

6

Duloxetine in the treatment of major depressive disorder: an open label study

Duloxetine in the treatment of major depressive disorder: an open label study

... In the current study, the rate of treatment response (≥50% reduction in HAMD 17 total score from baseline) was 67.9%, while the remission rate (HAMD 17 total score ≤7) was 52.8% (LOCF analysis). In two ...

11

A prospective, open label, pilot study to evaluate the role of sucralfate in the management of pressure ulcers

A prospective, open label, pilot study to evaluate the role of sucralfate in the management of pressure ulcers

... prospective, open label, pilot study to evaluate the role of Sucralfate in the management of pressure ulcers” has been done by me under the direct guidance of Dr Margaret Shanthi ...

114

Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study

Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study

... the open-label wait-listed RCT was an accept- able and feasible trial ...The open-label wait-listed RCT design is not a panacea to the chal- lenges that some placebo-controlled biomedical ...

23

A Prospective, Randomized, Open Label, Comparative Study of Resveratrol as an Add on Therapy in Systemic Hypertension

A Prospective, Randomized, Open Label, Comparative Study of Resveratrol as an Add on Therapy in Systemic Hypertension

... This is to certify that this dissertation work titled “A PROSPECTIVE, RANDOMIZED, OPEN LABEL, COMPARATIVE STUDY OF RESVERATROL AS AN ADD ON THERAPY IN SYSTEMIC HYPERTENSION” of the candidate Dr.G.SELVAM ...

117

NeuralClassifier: An Open source Neural Hierarchical Multi label Text Classification Toolkit

NeuralClassifier: An Open source Neural Hierarchical Multi label Text Classification Toolkit

... • Suitable for almost all text classification tasks: NeuralClassifier is designed for hierarchi- cal and multi-label classification, which naturally also supports binary-class and multi-class clas- sification, so ...

6

Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis : results from a phase IIa open‐label trial and subsequent phase III open‐label extension

Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis : results from a phase IIa open‐label trial and subsequent phase III open‐label extension

... Until recently, approved medications for adolescents with AD were limited to topical therapies, including topical corticos- teroids (TCS) and topical calcineurin inhibitors (TCIs); how- ever, their long-term application ...

13

Show all 10000 documents...

Related subjects